Kings Path Partners’s MetLife MET Stock Holding History

Kings Path Partners’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-224	Closed	-$18K	–	329
2025 Q2	$18K	Buy	+224	New	+$17.3K	0.01%	205

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kings Path Partners's MET Position: Q3 2025 in Review

Kings Path Partners sold out of MetLife (MET) in Q3 2025, closing a stake of 224 shares — an estimated $18K sold.

Kings Path Partners first reported a position in MET in Q2 2025 and held it in 1 quarter. The position peaked at $18K in Q2 2025. 1,363 funds tracked by Wall St. Rank hold MET as of Q3 2025.

Kings Path Partners reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
Kings Path Partners sold 224 MetLife shares in Q3 2025, an estimated $18K.
Kings Path Partners first reported a position in MetLife in Q2 2025 and held it in 1 quarter.
Kings Path Partners's MetLife position peaked at $18K in Q2 2025.
1,363 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Kings Path Partners's 13F filing for Q3 2025, filed 13 Jul 2026.